{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:05:55Z","timestamp":1790399155535,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.ijantimicag.2005.01.021","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T11:53:47Z","timestamp":1115812427000},"page":"464-468","source":"Crossref","is-referenced-by-count":30,"title":["Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages"],"prefix":"10.1016","volume":"25","author":[{"given":"Ruchi","family":"Sood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhvi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smitha","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Rattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.01.021_bib1","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1128\/AAC.40.6.1542","article-title":"Reporter gene technology to assess activity of antimycobacterial agents in macrophages","volume":"40","author":"Arain","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/AAC.43.5.1189","article-title":"Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model","volume":"43","author":"Cynamon","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0732-8893(91)90002-W","article-title":"Oxazolidinone a new class of synthetic antituberculosis agent: in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis","volume":"14","author":"Ashtekar","year":"1991","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/jm950956y","article-title":"Identification of novel oxazolidinone (U-100480) with potent antimycobacterial activity","volume":"39","author":"Barbachyn","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib5","unstructured":"National Committee for Clinical Laboratory Standards. Susceptibility testing of Mycobacteria, Nocardia, and other Aerobic Actinomycetes: Tentative Standard M24-T2 NCCLS, vol. 20, no. 26; 2000."},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.40.4.839","article-title":"In vitro activities of U-100592 andU-100766, novel oxazolidinone antibacterial agents","volume":"40","author":"Zuranko","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib7","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/AAC.43.5.1042","article-title":"Antimycobacterial activities of isoxyl and new derivatives through inhibition of mycolic acid synthesis","volume":"43","author":"Phetsuksiri","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/AAC.43.3.661","article-title":"Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C8 methoxyl group on survival in liquid media and in human macrophages","volume":"43","author":"Zhao","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib9","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/AAC.39.12.2692","article-title":"Antituberculosis activity of clarithromycin","volume":"39","author":"Luna-Herrera","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jac\/40.6.841","article-title":"Activity of new quinolones against intracellular Mycobacterium avium in human monocytes","volume":"40","author":"Venkataprasad","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1164\/ajrccm\/145.4_Pt_1.856","article-title":"Clarithromycin minimal inhibitory and bactericidal concentrations","volume":"145","author":"Heifets","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/AAC.37.1.111","article-title":"MIC and MBC of clarithromycin against Mycobacterium avium within human macrophages","volume":"37","author":"Mor","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib13","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/AAC.34.8.1508","article-title":"Activities of clarithromycin, sulfisoxazole and rifabutin against Mycobacterium avium complex multiplication within human macrophages","volume":"34","author":"Perronne","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib14","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1128\/AAC.36.11.2413","article-title":"Activity of clarithromycin against Mycobacterium avium infection in beige mice","volume":"36","author":"Klemens","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.01.021_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-117-3-257","article-title":"Multidrug-resistant tuberculosis","volume":"117","author":"Dooley","year":"1992","journal-title":"Ann Int Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T20:36:12Z","timestamp":1550608572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0924857905000841"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.01.021","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}